Belite Bio, Inc Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.02M-0.02M-0.03M-0.02M
Gross Profit -0.02M-0.02M-0.03M-0.02M
Operating items
Research & Development 3.69M7.42M8.87M24.84M29.94M
Selling, General & Administrative 2.06M2.38M3.95M6.82M10.06M
Operating Expenses 5.74M9.80M12.82M31.67M40.00M
Operating Income -5.74M-9.80M-12.82M-31.67M-40.00M
EBIT -5.74M-9.80M-12.82M-31.67M-40.00M
Non-operating items
Interest & Investment Income 0.01M0.01M0.02M0.07M3.74M
Other Non Operating Income -0.01M0.13M0.17M-0.00M0.14M
Non Operating Income -0.01M0.13M0.17M0.04M3.86M
Net income details
EBT -5.75M-9.67M-12.65M-31.62M-36.14M
Tax Provisions 0.00M0.01M0.01M
Profit After Tax -5.75M-9.67M-12.65M-31.63M-36.14M
Investment Income 0.01M-0.15M-196.00M18.00M-286.00M
Income from Continuing Operations -5.75M-9.67M-12.65M-31.63M-36.14M
Consolidated Net Income -5.75M-9.67M-12.65M-31.63M-36.14M
Income towards Parent Company -5.75M-9.67M-12.65M-31.63M-36.14M
Net Income towards Common Stockholders -5.75M-9.67M-12.65M-31.63M-36.14M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 24.10M24.10M24.90M29.15M
EBITDA -5.75M-9.82M-12.84M-31.61M-36.43M